Catheter Precision, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $432.0K | $238.0K | $226.0K | $212.0K | $143.0K | $149.0K | $96.0K |
| Cost of Revenue | $921.0K | $42.0K | $20.0K | $18.0K | $14.0K | $11.0K | $11.0K | $10.0K |
| Gross Profit | $98.0K | $390.0K | $218.0K | $208.0K | $198.0K | $132.0K | $138.0K | $86.0K |
| Gross Margin | 9.6% | 90.3% | 91.6% | 92.0% | 93.4% | 92.3% | 92.6% | 89.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | $91.0K | $63.0K |
| SG&A Expense | $3.9M | $2.6M | $2.8M | $3.0M | $2.9M | $3.5M | $3.1M | $2.9M |
| Operating Income | $-4.0M | $-2.3M | $-9.9M | $-3.0M | $-4.7M | $-3.6M | $-3.1M | $-2.9M |
| Operating Margin | -388.1% | -536.6% | -4,143.3% | -1,336.7% | -2,210.4% | -2,500.0% | -2,047.7% | -2,978.1% |
| Interest Expense | — | — | — | — | — | — | — | $32.0K |
| Pretax Income | $-3.6M | $-1.9M | $-6.1M | $-2.3M | $-6.4M | $-4.8M | $-2.5M | $-4.1M |
| Income Tax Expense | $-312.0K | $-175.0K | $-214.0K | $78.0K | $-950.0K | $-724.0K | $3.1M | $0 |
| Net Income | $-3.3M | $-1.7M | $-5.8M | $-2.3M | $-5.1M | $-4.0M | $-5.6M | $-4.1M |
| Net Margin | -323.4% | -389.1% | -2,427.7% | -996.0% | -2,409.9% | -2,828.7% | -3,777.2% | -4,291.7% |
| EPS (Basic) | $-0.92 | $-1.39 | $-0.11 | $-0.28 | $-7.28 | $-6.81 | $-79.57 | $-6.36 |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 2.8M | 2.2M | 1.1M | 7.9M | 701.9K | 593.9K | 171.8K | 647.7K |
| Shares Outstanding (Diluted) | 2.8M | 2.2M | 1.1M | 7.9M | 701.9K | 593.9K | 171.8K | 647.7K |
| Dividends Per Share | — | — | — | — | — | — | — | — |